Global Thyroid Disorder Market Size By Type (Hypothyroidism, Hyperthyroidism), By Treatment (Medications, Radioactive Iodine Therapy), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Clinics), By Geographic Scope And Forecast

Thyroid Disorder Market Size And Forecast

Thyroid Disorder Market size was valued at USD 2.46 Billion in 2024 and is projected to reach USD 3.35 Billion by 2032, growing at a CAGR of 3.17 % during the forecast period 2026-2032.

The rising number of thyroid gland disorders, the introduction of new effective combination drug therapies, and the growing number of cases requiring effective combination drug therapies are some of the factors anticipated to foster market growth during the forecast period. The Global Thyroid Disorder Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Thyroid Disorder Market Definition

Thyroid disorders are medical conditions affecting the proper functioning of the thyroid gland. The thyroid gland is an endocrine gland located in the middle of lower the neck and is responsible for the production of thyroid hormones which help to regulate various metabolic activities in the body. The thyroid controls the body's cells use energy from food, a process called metabolism. Among other things, metabolism affects the body's temperature, heartbeat, and how well the body burns calories. If the body doesn't have enough thyroid hormone, human body processes slow down.

When the thyroid gland does not produce enough thyroid hormones (hypothyroidism) or too much hormone (hyperthyroidism), the metabolism and functioning of the body are disrupted. The lack of iodine in the body is a major factor that leads to thyroid disorders. All thyroid diseases can be treated, resulting in normal thyroid function. However, this frequently requires being on medication to maintain a normal thyroid state. Most patients with thyroid disorders can be cured through surgery and radioactive iodine treatments.

Global Thyroid Disorder Market Overview

The major factors that drive the growth of the market include an increase in the incidence of thyroid gland disorder, a rise in the number of disease awareness programs, especially in developing countries, and the development of effective combination drug therapies to treat thyroid gland disorder. A government organization across the globe has increased the awareness about timely diagnosis and treatment of thyroid disorders hence promoting the growth of the market. In addition, pharmaceutical manufacturers are also undertaking initiatives to support awareness campaigns or implement promotional strategies to create awareness anticipated to propel the growth of the market.

The market for thyroid disorders is primarily driven by the increasing number of patients with iodine deficiency cause of very less good sources of iodine in the diet can drive the market growth. Research and the development of medicines for thyroid-related disorders and an increase in the investments made in the pharmaceutical sector can drive the market. However, factors such as the high cost of treatment procedures such as radioactive iodine (RAI) therapy and side effects related to the available therapeutics might restrain the market growth to an extent.

Global Thyroid Disorder Market: Segmentation Analysis

The Global Thyroid Disorder Market is Segmented on the basis of Type, Treatment, Route Of Administration, End User, and Geography.

Thyroid Disorder Market, By Type

• Hypothyroidism
• Hyperthyroidism

Based on Type, The market is bifurcated into Hypothyroidism and Hyperthyroidism. If the body makes too much thyroid hormone, the body can develop a condition called hyperthyroidism. If the body makes too little thyroid hormone, it's called hypothyroidism. Both conditions are serious and need to be treated with effective drug therapies. Hypothyroidism is expected to gain significant traction over the forecast period. A growing population base diagnosed with the condition and the rising prevalence of iodine deficiency population across the globe is some of the factors that boost the market growth.

Thyroid Disorder Market, By Treatment

• Medications
• Radioactive Iodine Therapy
• Surgery

Based on Treatment, The market is bifurcated into Medications, Radioactive Iodine Therapy and Surgery. Medication that boosts your levels of thyroid hormone is an easy way to treat hypothyroidism. It's not a cure, but it can keep patients' conditions under control for the long term. Also, radioactive iodine therapy is the most widely recommended permanent treatment of hyperthyroidism. This treatment takes advantage of the fact that thyroid cells are the only cells in the body that can absorb iodine.

Thyroid Disorder Market, By Route of Administration

• Oral
• Intravenous
• Others

Based on the Route Of Administration, The market is bifurcated into Oral, Intravenous, and Others. The oral route of the administration segment is the largest contributor toward market growth. Most of the medications available in the market are in the form of tablets or pills and can be easily administered by patients.

Thyroid Disorder Market, By End User

• Hospitals
• Clinics
• Others

Based on End Users, The market is bifurcated into Hospitals, Clinics, and Others.

Thyroid Disorder Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, The Global Thyroid Disorder Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is dominating the thyroid gland disorder market. Multinational companies are frequently involved in raising awareness in American society through campaigns driving the growth of the market in the region. The Asia Pacific is expected to have significant growth during the forecast period owing to the growing population base affected with thyroid disorder is increasing demand for drugs that are further expected to boost the growth of the market.

Key Players

The "Global Thyroid Disorder Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Lannett Company, Inc., Allergan plc., Mylan N.V., GlaxoSmithKline plc., Novartis AG, RLC LABS, Inc., and Abbott Laboratories.

• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.